19 completed, 3 unknown, 2 not yet recruiting, 1 recruiting. 25 Phase 1, 7 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 25 | Completed 19, Unknown 3, Not yet recruiting 2, Recruiting 1 |
| Phase 2 | 7 | Completed 6, Unknown 1 |
Follow Benign Prostatic Hyperplasia: new trials by email Literature Review of Benign Prostatic Hyperplasia trials Research Report on Benign Prostatic Hyperplasia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Clinical Trial to Evaluate the Bioequivalence of AD-116A Compared to AD-1161 in Healthy Adult Male Volunteers AD-116A, AD-1161 - Benign Prostatic Hyperplasia | Phase 1 | Not yet recruiting | Addpharma Inc. | 44 | 2026-07-01 | 2026-07-20 |
| A Clinical Trial to Evaluate the Bioequivalence of AD-116A and AD-1161 Under Fed Conditions in Healthy Adult Male Volunteers AD-116A, AD-1161 - Benign Prostatic Hyperplasia | Phase 1 | Not yet recruiting | Addpharma Inc. | 44 | 2026-07-01 | 2026-07-27 |
| A Study to Evaluate the Safety and Pharmacokinetics of AD-116 and AD-1161 in Healthy Adult Male Subjects AD-116, AD-1161 - Benign Prostatic Hyperplasia | Phase 1 | Recruiting | Addpharma Inc. | 44 | 2026-02-26 | 2026-03-03 |
| A Clinical Trial to Evaluate the Safety and the Pharmacokinetics of AD-116 Compared to AD-1161 in Healthy Adult Male Volunteers AD-116, AD-1161 - Benign Prostatic Hyperplasia | Phase 1 | Completed | Addpharma Inc. | 44 | 2026-01-22 | 2026-07-28 |
| BOTOX Injection Technique for LUTS Due to BPH Botulinum Toxin Type A (BoNT-A) - Benign Prostatic Hyperplasia | Phase 1 | Completed | Benha University | 60 | 2025-10-01 | 2026-06-12 |
| Study to Evaluate the Bioequivalence of Astellas Phama Korea Inc. "Harnal-D" in Healthy Volunteers Harnal-D Tab., Chong Kun Dang Tamsulosin HCl Tab. - Benign Prostatic Hyperplasia | Phase 1 | Completed | Chong Kun Dang Pharmaceutical | 30 | 2019-03-11 | 2020-01-30 |
| Study to Evaluate the Bioequivalence of Astellas Phama Korea Inc. "Harnal-D" in Healthy Volunteers After Meal Harnal-D Tab., Chong Kun Dang Tamsulosin HCl Tab. - Benign Prostatic Hyperplasia | Phase 1 | Completed | Chong Kun Dang Pharmaceutical | 30 | 2019-03-11 | 2020-01-30 |
| The Effect of Traditional Chinese Medicine on Benign Prostatic Hyperplasia VGH-BPH1, Placebo (Corn starch pill manufactured to mimic VGH-BPH1) - Benign Prostatic Hyperplasia | Phase 1 / Phase 2 | Completed | Taipei Veterans General Hospital, Taiwan | 23 | 2019-03-06 | 2020-04-13 |
| Pharmacokinetics and Safety/Tolerability of YY-201 in Comparison to Dutasteride and Tadalafil Dutasteride 0.5 mg, Tadalafil 5 mg, YY-201 - Benign Prostatic Hyperplasia | Phase 1 | Completed | Yuyu Pharma, Inc. | 36 | 2017-03-27 | 2017-11-24 |
| Effectiveness and Safety of Adipose-derived Regenerative Cells for Reduction of Risk of Bladder Neck Contracture Liposuction, Transurethral bladder neck resection., ADRC - Bladder Neck Obstruction, Bladder Outlet Obstruction | Phase 1 / Phase 2 | Unknown | Central Clinical Hospital w/Outpatient Health Center of Business Administration for the President of Russian Federation | 12 | 2016-01-01 | 2016-08-16 |
| Study to Compare the Safety and Pharmacokinetics of CKD-397 CKD-397, TD+TM - Benign Prostatic Hyperplasia | Phase 1 | Completed | Chong Kun Dang Pharmaceutical | 36 | 2015-11-01 | 2016-01-12 |
| The PK Study of the JLP-1207 and Solifenacin/Tamsulosin in Healthy Male Volunteers. JLP-1207, Solifenacin 5mg+Tamsulosin 0.2mg - LUTS(Lower Urinary Tract Symptoms), Benign Prostatic Hyperplasia | Phase 1 | Completed | Jeil Pharmaceutical Co., Ltd. | 54 | 2015-08-01 | 2016-06-24 |
| Investigate the Effect of Food on the Pharmacokinetic of JLP-1207 in Healthy Male Volunteers JLP-1207(Fasted), JLP-1207(Fed) - LUTS, Benign Prostatic Hyperplasia | Phase 1 | Completed | Jeil Pharmaceutical Co., Ltd. | 54 | 2015-07-01 | 2016-06-24 |
| Clinical Trial to Investigate the Pharmacokinetic Drug Interaction Between Solifenacin and Tamsulosin Tamsulosin, Solifenacin, Tamsulosin and solifenacin - LUTS, Benign Prostatic Hyperplasia | Phase 1 | Completed | Jeil Pharmaceutical Co., Ltd. | 36 | 2014-07-01 | 2016-06-24 |
| Evaluating a Pharmacokinetic Drug Interaction Between Tadalafil and Tamsulosin Tadalafil, Tamsulosin, Tadalafil + Tamsulosin - Erectile Dysfunction, Benign Prostatic Hyperplasia | Phase 1 | Completed | Hanmi Pharmaceutical Company Limited | 30 | 2014-03-01 | 2014-09-12 |
| Prostate Embolization for Benign Prostatic Hyperplasia Prostatic Embolization with Embosphere Micropsheres - Benign Prostatic Hyperplasia | Phase 1 / Phase 2 | Completed | James B. Spies, MD | 15 | 2013-08-01 | 2019-12-10 |
| Study of PRX302 for Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia (BPH) PRX302, Placebo - Benign Prostatic Hyperplasia | Phase 1 / Phase 2 | Completed | Sophiris Bio Corp | 40 | 2011-09-01 | 2013-08-21 |
| A Study of Tadalafil in Benign Prostatic Hyperplasia Tadalafil - Benign Prostatic Hyperplasia | Phase 1 | Completed | Eli Lilly and Company | 24 | 2010-07-01 | 2012-05-16 |
| A Study Evaluating the Effect of Botulinum Toxin Type A on Semen Quality in Patients With Benign Prostatic Hyperplasia Botulinum Toxin Type A, Placebo (saline) - Benign Prostatic Hyperplasia | Phase 1 / Phase 2 | Completed | Allergan | 61 | 2009-08-01 | 2013-09-30 |
| EC905 Pharmacokinetic Profile Study Tamsulosin HCl, Solifenacin Succinate, EC905 - Phase 1, Healthy | Phase 1 | Completed | Astellas Pharma Europe B.V. | 46 | 2009-03-01 | 2015-12-18 |
Showing 20 of 25. Sign in to see all of them.
Prostatic Hyperplasia (25) · Lower Urinary Tract Symptoms (5) · Urinary Bladder, Overactive (4) · Urinary Bladder Neck Obstruction (2) · Erectile Dysfunction (1) · Prostatic Diseases (1) · Prostatitis (1) · Urinary Incontinence (1)
Genital Diseases (25) · Genital Diseases, Male (25) · Male Urogenital Diseases (25) · Urogenital Diseases (25) · Prostatic Diseases (24) · Pathological Conditions, Signs and Symptoms (7) · Signs and Symptoms (7) · Urological Manifestations (7) · Female Urogenital Diseases (5) · Female Urogenital Diseases and Pregnancy Complications (5) · Urinary Bladder Diseases (5) · Urologic Diseases (5) · Lower Urinary Tract Symptoms (2) · Urethral Diseases (2) · Urethral Obstruction (2)
Tamsulosin (4) · Solifenacin Succinate (3) · Tadalafil (3) · Botulinum Toxins, Type A (2) · Dutasteride (1) · Embryo Implantation (1) · Ethanol (1) · Lipectomy (1) · PRX302 (1) · Photochemotherapy (1) · QLT0074 (1) · Sodium Chloride (1) · Starch (1) · Talaporfin (1) · incobotulinumtoxinA (1)
Addpharma Inc. (4) · Chong Kun Dang Pharmaceutical (3) · Jeil Pharmaceutical Co., Ltd. (3) · Allergan (1) · American Medical Systems (1) · Astellas Pharma Europe B.V. (1) · Benha University (1) · Central Clinical Hospital w/Outpatient Health Center of Business Administration for the President of Russian Federation (1) · Eli Lilly and Company (1) · Hanmi Pharmaceutical Company Limited (1) · James B. Spies, MD (1) · Light Sciences Oncology (1) · ProstaPlant Urology System Ltd. (1) · QLT Inc. (1) · Sophiris Bio Corp (1)
South Korea (10) · United States (6) · Canada (1) · Egypt (1) · Germany (1) · Israel (1) · Netherlands (1) · Russia (1) · Taiwan (1)
Kyung-sang Yu, M.D., Ph.D. (2) · Yu-Jung Cha (2) · Andrey A Pulin, MD, PhD (1) · Andrey Z Vinarov, MD, PhD, Prof (1) · Denis V Butnaru, MD, PhD (1) · Hyeong-Seok Lim, M.D.,Ph.D. (1) · Jack Baniel, Prof. (1) · Kyung-sang Yu, M.D.,Ph.D. (1) · Leland Ronningen, MD (1) · Min Kyu Park, MD, PhD (1) · Richard C. Yocum, MD (1) · Shinn-Jang Hwang, M.D. (1)